← Leaderboards
Thomas M Huckaba
Xavier University Of Louisiana
$1,370,138
Attributed
$1,370,138
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $514.2K · FY2023–25$1M$750K$500K$250K$0
'23
'24
'25
Funding mix
By agency
NIH$1,370,138 · 1
By mechanism
U54$1,370,138 · 1
Top collaborators
No co-investigators on record.
Most similar at Xavier University Of Louisiana
Same institution · by research overlap
- Guangdi Wang$13,394,490
Others in their field
Other Rising Stars on “Complex”
- Rebecca Montalvan · Westat, Inc.$86,600,000
- Gary Mays · Axle Informatics, Llc$58,129,860
- Jeffrey Leintz · National Opinion Research Center$40,628,545
- Maximilian Haeussler · University Of California Santa Cruz$13,899,136
- Samuel W Teitelbaum · Arizona State University$13,377,213
- Jason Dickens · Duke University$12,259,409
Research focus
ComplexCoupledAlk GeneActive SitesBindingAmericanBiological AvailabilityAmerican Cancer SocietyCancer CellAnaplastic Lymphoma KinaseCancer ComplicationCancer DiagnosisBinding ProteinsCancer RelapseCanis FamiliarisCell ModelCell ProliferationCellular AssayChimeric ProteinsChromosomesClinicClinically RelevantCoiled-Coil DomainCrizotinib
Grant awards (3)
Developing a Selective PROTAC of Anaplastic Lymphoma Kinase for Treatment of ALK+ NSCLC$493,320
U54 · FY2025 · MD · contact PI
Developing a Selective PROTAC of Anaplastic Lymphoma Kinase for Treatment of ALK+ NSCLC$514,185
U54 · FY2024 · MD · contact PI
Developing a Selective PROTAC of Anaplastic Lymphoma Kinase for Treatment of ALK+ NSCLC$362,633
U54 · FY2023 · MD · contact PI